Because KMC14 cells had self-renewal capacity, differentiation ability and in vivo tumorigenicity, and expressed pancreatic cancer stem cell markers, it seems possible that KMC14 cells might be a subpopulation of CD133+ pancreatic cancer stem cells enriched by gemcitabine. Here, PROM1 is linked to pancreatic neoplasm.